Home
Deutsch
Advanced Search
Browse by ...
Publication overview
Contact persons
Help
Publ. Version/Full Text Volltext
DOI
PMC
 |
Free journal |
|
as soon as is submitted to ZB.
The parallel universe: MicroRNAs and their role in chronic hepatitis, liver tissue damage and hepatocarcinogenesis.
Swiss Med. Wkly. 141:w13287 (2011)
In recent years, enormous progress has been made in identifying microRNAs (miRNAs) as important regulators of gene expression and their association with or control of various liver diseases such as fibrosis, hepatitis and hepatocellular carcinoma (HCC). Indeed, many genes encoding miRNAs as well as their targets have been described and their direct or indirect link to the respective liver diseases has been investigated in various experimental systems as well as in human tissue. Here we discuss current knowledge of miRNAs and their involvement in liver diseases, elaborating in particular on the contribution of miRNAs to hepatitis, fibrosis and HCC formation. We also debate possible prognostic, predictive and therapeutic values of respective miRNAs in liver diseases. The discovery of liver disease related miRNAs has constituted a major breakthrough in liver research and will most likely be of high relevance for future therapeutic strategies, especially when dealing with hepatitis, fibrosis and HCC.
Altmetric
Additional Metrics?
Edit extra informations
Login
Publication type
Article: Journal article
Document type
Review
Keywords
chronic hepatitis; hepatocellular carcinoma; fibrosis; miRNA; HUMAN HEPATOCELLULAR-CARCINOMA; NON-TUMOROUS TISSUES; C VIRUS-RNA; NF-KAPPA-B; SUPPRESSES TUMORIGENICITY; REGULATES EXPRESSION; GENE-EXPRESSION; IN-VIVO; CANCER; CELLS
ISSN (print) / ISBN
0036-7672
e-ISSN
1424-3997
Journal
Swiss Medical Weekly
Quellenangaben
Volume: 141,
Article Number: w13287
Publisher
EMH Schweizerischer Ärzteverlag
Publishing Place
Basel
Non-patent literature
Publications
Reviewing status
Peer reviewed
Institute(s)
Institute of Virology (VIRO)